Hospital Mater DeiBSP:MATD3 +3.18%85 OCF Margin % is 0.10% as of Mar. 2026, which is 99% below its 10-year median of 10.73. GuruFocus rates BSP:MATD3 with a GF Score™ of 85/100 and a GF Value™ of R$5.85 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 669 Healthcare Providers & Services companies, Hospital Mater Dei ranks worse than 52.62% on this metric.
The historical rank and industry rank for Hospital Mater Dei's OCF Margin % or its related term are showing as below:
BSP:MATD3'
s OCF Margin % Range Over the Past 10 Years
Min: 5.58 Med: 10.73 Max: 26.98
Current: 7.69
During the past 9 years, the highest OCF Margin % of Hospital Mater Dei was 26.98%. The lowest was 5.58%. And the median was 10.73%.
BSP:MATD3's OCF Margin % is ranked worse than 52.62% of 669
companies
in the Healthcare Providers & Services industry
Industry Median: 8.29
vs BSP:MATD3: 7.69
Hospital Mater Dei OCF Margin % Related Terms
Hospital Mater Dei OCF Margin % Historical Data
* Premium members only.
The historical data trend for Hospital Mater Dei's OCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BSP:MATD3 vs HCA, THC, DVA: OCF Margin % Comparison
For the Medical Care Facilities subindustry, Hospital Mater Dei's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Hospital Mater Dei OCF Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Hospital Mater Dei's OCF Margin % distribution charts can be found below:
* The bar in red indicates where Hospital Mater Dei's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Hospital Mater Dei (BSP:MATD3) has a OCF Margin % of 0.10% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Hospital Mater Dei and its competitors. This is 99% below median its historical median of 10.73. Over the past decade, Hospital Mater Dei's OCF Margin % has ranged from 5.58 to 26.98. According to the industry distribution chart, Hospital Mater Dei ranks #352 out of 669 companies in the Healthcare Providers & Services industry, placing it in the top 52.6%.
Is Hospital Mater Dei's OCF Margin % too high?
Hospital Mater Dei's current OCF Margin % of 0.10% is 99% below median its 10-year median of 10.73. Over the past 10 years, this metric has ranged from a low of 5.58 to a high of 26.98. The Healthcare Providers & Services industry median OCF Margin % is 8.29. Hospital Mater Dei's value of 0.10% is 98.8% below this industry median. Based on the distribution chart, Hospital Mater Dei ranks #352 out of 669 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Hospital Mater Dei has a GF Score™ of 85/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Hospital Mater Dei's OCF Margin % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Hospital Mater Dei ranks #352 out of 669 companies for OCF Margin %. This places Hospital Mater Dei in the lower half of its industry. The industry median OCF Margin % is 8.29. Hospital Mater Dei's value of 0.10% is 98.8% below this benchmark. Historically, Hospital Mater Dei's own OCF Margin % has ranged from 5.58 to 26.98 over the past decade. While the company's 10-year median is 10.73 vs. the industry median of 8.29, Hospital Mater Dei has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Healthcare Providers & Services company?
The median OCF Margin % among Healthcare Providers & Services companies is 8.29, based on 669 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Hospital Mater Dei's current OCF Margin % of 0.10% is 98.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Hospital Mater Dei and its competitors. For the Healthcare Providers & Services industry, the median OCF Margin % is 8.29 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Hospital Mater Dei's current OCF Margin % is 0.10%, which is 99% below median its own 10-year median of 10.73. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hospital Mater Dei stock overvalued right now?
Based on GuruFocus' analysis, Hospital Mater Dei (BSP:MATD3) is currently considered Modestly Undervalued. The stock's GF Value™ is R$5.85, compared to a current price of R$4.86 — trading 16.9% below its estimated fair value. The current OCF Margin % is 0.10%, which is 99% below median its 10-year median of 10.73 and 98.8% below the Healthcare Providers & Services industry median of 8.29. Hospital Mater Dei's overall GF Score™ is 85/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Hospital Mater Dei (BSP:MATD3), the current OCF Margin % is 0.10% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Hospital Mater Dei (BSP:MATD3) Overvalued in 2026?
Based on GuruFocus' analysis, Hospital Mater Dei stock appears to be undervalued.
The current stock price of R$4.86 is trading 16.9% below its estimated GF Value™ of R$5.85.
GuruFocus considers Hospital Mater Dei to be Modestly Undervalued.
Key valuation signals for BSP:MATD3:
OCF Margin %: 0.10% (99% below median its 10-year median of 10.73)
GF Value™: R$5.85 vs. price of R$4.86 (16.9% below fair value)
Industry Position: 98.8% below the Healthcare Providers & Services median (#352 of 669)
No single metric tells the full story. See the BSP:MATD3 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Hospital Mater Dei SA is an integrated healthcare ecosystem that provides hospital and oncological services. The company provides a wide range of healthcare services, including hospitalizations, surgeries, oncology treatments, medical appointments, and diagnostic exams.
85GF Score
Get the complete analysis for BSP:MATD3
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BSP:MATD3 has been successfully added to your 
